Get the Stockscreener App
1.29
0.78%
0.01
Novabridge Biosciences Adr Stock (NBP) Forecast
The Novabridge Biosciences Adr (NBP) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.6759, representing a -47.60% decrease from the current price of $1.29. The highest analyst price target is $1.1832, and the lowest is $0.1687.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NBP Price Target
Average 1.0278
(-20.32% Downside)
Is Novabridge Biosciences Adr (NBP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 29.40 | Buy |
| STOCH(9,6) | 27.28 | Neutral |
| STOCHRSI(14) | 39.70 | Neutral |
| MACD(12,26) | -0.095 | Buy |
| ADX(14) | 40.03 | Sell |
| William %R | -83.33 | Buy |
| CCI(14) | -36.04 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.343
Sell
|
1.3397
Sell
|
| MA20 |
1.4013
Sell
|
1.4089
Sell
|
| MA50 |
1.6409
Sell
|
1.5651
Sell
|
| MA100 |
1.6881
Sell
|
1.7969
Sell
|
| MA200 |
2.3285
Sell
|
2.4256
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, NBP could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on NBP, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 29.4 indicates that NBP is oversold. This indicates that NBP price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 27.28 indicates that NBP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 39.7 indicates that NBP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 40.03 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -36.04 indicates that NBP is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term NBP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Novabridge Biosciences Adr financial reports and earnings history, Novabridge Biosciences Adr (NBP) stock could reach $9.66 by 2030, $40.43 by 2040 and $61.96 by 2050. See the projected annual prices until 2050 of the Novabridge Biosciences Adr stock below:
- Novabridge Biosciences Adr (NBP) is expected to reach an average price of $14.92 in 2035, with a high prediction of $15.81 and a low estimate of $14.98. This indicates an $1,056% rise from the last recorded price of $1.29.
- Novabridge Biosciences Adr (NBP) stock is projected to chart a bullish course in 2040, with an average price target of $38.14, representing an $2,857% surge from its current level. The forecast ranges from a conservative $38.22 to a sky-high $40.43.
- Our analysts predict Novabridge Biosciences Adr (NBP) to jump 1,957% by 2045, soaring from $26.61 to an average price of $26.54, potentially reaching $29.44. While $26.61 is the low estimate, the potential upside is significant.
- Novabridge Biosciences Adr (NBP) stock is expected to climb by 2050, reaching an average of $58.56, a $4,439% jump from its current level. However, a wide range of estimates exists, with high and low targets of $61.96 and $58.81, respectively, highlighting the market's uncertainty.
Novabridge Biosciences Adr Stock (NBP) Year by Year Forecast
Novabridge Biosciences Adr Stock (NBP) Price Forecast for 2026
The predicted value for Novabridge Biosciences Adr (NBP) in 2026 is set at an average of $2.6793. Estimates vary from a peak of $5.19 to a trough of $0.1687, indicating an +107.70% surge from the present price of $1.29.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.6064 | $0.1687 | $1.1832 | -52.99% |
| December, 2026 | $1.0774 | $0.5642 | $1.3619 | -16.48% |
Novabridge Biosciences Adr Stock (NBP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Novabridge Biosciences Adr (NBP) is $1.3748, with a high forecast of $2.7391 and a low forecast of $0.0105. This indicates an +6.57% increase from the last price of $1.29.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.3083 | $0.2483 | $2.0451 | -76.10% |
| February, 2027 | $0.4693 | $0.096 | $0.8138 | -63.62% |
| March, 2027 | $0.1121 | $0.0947 | $1.097 | -91.31% |
| April, 2027 | $0.0689 | $0.0539 | $0.3512 | -94.66% |
| May, 2027 | $0.3724 | $0.0284 | $0.3366 | -71.13% |
| June, 2027 | $0.4515 | $0.3147 | $0.3246 | -65.00% |
| July, 2027 | $0.1395 | $0.0105 | $0.4995 | -89.19% |
| August, 2027 | $0.4381 | $0.0154 | $0.4481 | -66.03% |
| September, 2027 | $0.4691 | $0.306 | $0.5836 | -63.64% |
| October, 2027 | $0.225 | $0.1273 | $0.5418 | -82.55% |
| November, 2027 | $3.2445 | $0.2178 | $2.32 | +151.51% |
| December, 2027 | $2.6826 | $3.0736 | $2.7391 | +107.96% |
Novabridge Biosciences Adr Stock (NBP) Price Forecast for 2028
In 2028, Novabridge Biosciences Adr (NBP) is projected to reach an average price of $3.3617, with a high projection of $5.99 and a low estimate of $0.7335. This indicates an +160.60% rise from the last price of $1.29.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.1153 | $2.2353 | $2.5673 | +63.97% |
| February, 2028 | $2.6934 | $2.3888 | $2.2543 | +108.79% |
| March, 2028 | $2.3415 | $2.5915 | $2.367 | +81.51% |
| April, 2028 | $2.6996 | $2.466 | $2.4696 | +109.27% |
| May, 2028 | $2.3122 | $2.3272 | $2.5661 | +79.24% |
| June, 2028 | $2.5603 | $2.2163 | $2.1606 | +98.47% |
| July, 2028 | $2.403 | $2.4094 | $2.4549 | +86.28% |
| August, 2028 | $1.6211 | $1.7565 | $2.1475 | +25.66% |
| September, 2028 | $1.3892 | $1.5542 | $1.4656 | +7.69% |
| October, 2028 | $0.8618 | $0.9568 | $1.0737 | -33.19% |
| November, 2028 | $0.9149 | $0.9059 | $0.8699 | -29.08% |
| December, 2028 | $6.06 | $0.7335 | $5.99 | +369.77% |
Novabridge Biosciences Adr Stock (NBP) Price Forecast for 2029
The 2029 price forecast for Novabridge Biosciences Adr Stock (NBP) is $4.1942 on average, with a high prediction of $6.3136 and a low estimate of $2.0749. This represents an +225.13% increase from the previous price of $1.29.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $6.114 | $6.6004 | $6.3136 | +373.95% |
| February, 2029 | $5.7411 | $5.7243 | $5.9508 | +345.05% |
| March, 2029 | $5.2583 | $5.4279 | $5.3515 | +307.62% |
| April, 2029 | $5.1522 | $5.4022 | $5.2254 | +299.40% |
| May, 2029 | $5.3194 | $5.229 | $5.0894 | +312.36% |
| June, 2029 | $4.5865 | $4.9365 | $5.1382 | +255.55% |
| July, 2029 | $4.7505 | $4.5019 | $4.4533 | +268.26% |
| August, 2029 | $4.5077 | $4.5041 | $4.5973 | +249.43% |
| September, 2029 | $3.2848 | $3.5648 | $4.1844 | +154.64% |
| October, 2029 | $2.9588 | $3.1238 | $3.1784 | +129.36% |
| November, 2029 | $2.3159 | $2.3359 | $2.5956 | +79.53% |
| December, 2029 | $2.0549 | $2.0749 | $2.1577 | +59.29% |
Novabridge Biosciences Adr Stock (NBP) Price Forecast for 2030
Novabridge Biosciences Adr Stock (NBP) is expected to reach an average price of $5.8092 in 2030, with a high forecast of $9.8881 and a low forecast of $1.7302. This signifies an +350.32% surge from the last price of $1.29.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $9.73 | $1.7302 | $9.66 | +654.26% |
| February, 2030 | $10.08 | $10.12 | $9.8881 | +681.10% |
| March, 2030 | $8.8124 | $9.0124 | $9.5453 | +583.13% |
| April, 2030 | $8.3077 | $8.4877 | $8.6015 | +544.01% |
| May, 2030 | $8.1439 | $8.3826 | $8.0839 | +531.31% |
| June, 2030 | $8.1101 | $7.992 | $7.8131 | +528.69% |
| July, 2030 | $7.0154 | $7.3654 | $7.7102 | +443.83% |
| August, 2030 | $6.7516 | $6.7875 | $6.8344 | +423.38% |
| September, 2030 | $6.5069 | $6.5369 | $6.7397 | +404.41% |
| October, 2030 | $5.0931 | $5.3731 | $6.1359 | +294.81% |
| November, 2030 | $4.8693 | $4.8893 | $4.8912 | +277.46% |
| December, 2030 | $3.6946 | $3.7146 | $4.5083 | +186.40% |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):